Callan Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$15.9M |
| 2 |
State Street SPDR S&P Dividend ETF
SDY
|
+$3.49M |
| 3 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$3.38M |
| 4 |
Alerian MLP ETF
AMLP
|
+$2.45M |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
+$2.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Active Bond Exchange-Traded Fund
BOND
|
+$697K |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$583K |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$504K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$397K |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$392K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 97.97% |
| 2 | Healthcare | 1.8% |
| 3 | Materials | 0.23% |
Similar funds
Callan Capital's Q4 2013 Portfolio in Review
As of Q4 2013, Callan Capital held 59 positions worth $262M, up 25% from $210M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Callan Capital deployed $36.5M of net new capital in Q4 2013, opening 13 new positions and adding to 28 existing holdings. Its largest new stake was RECEPTOS INC COM STK (DE): 594,142 shares worth $17.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 98% of assets, down from 98% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was PIMCO Active Bond Exchange-Traded Fund, an estimated $697K trimmed.
- Callan Capital's largest Q4 2013 buy was RECEPTOS INC COM STK (DE): 594,142 shares worth $17.2M.
- Callan Capital added most to State Street SPDR S&P Dividend ETF in Q4 2013, an estimated $3.49M increase.
- Callan Capital's biggest Q4 2013 reduction was PIMCO Active Bond Exchange-Traded Fund, cutting an estimated $697K.
- Callan Capital fully exited Vanguard Short-Term Bond ETF in Q4 2013, selling an estimated $504K.
- Callan Capital's ten largest holdings make up 72% of its $262M portfolio in Q4 2013.
- Callan Capital opened 13 new positions and closed 5 in Q4 2013.
- Callan Capital's portfolio value rose 25% quarter-over-quarter to $262M.
Based on Callan Capital's 13F filing for Q4 2013, filed 12 Feb 2014.